Abstract
Mesa Biotech has obtained the FDA's 510(k) clearance for its Accula Strep A test, a diagnostic for Group A streptococcus infection. The agency's clearance allows the test to be used to diagnose Strep A in both children and adults in point-of-care settings and delivers laboratory quality results in 30 minutes, the company said.
Key Data
-
Publication Date11 December 2020
-
Primary AuthorWCG Clinical
-
SourceWCG Clinical
-
LanguageEnglish
Click below to visit original source: